Purpose To practice corporate sustainability, comply with environmental and energy regulations and international standards, and achieve environmental goals, these Regulations are established in accordance with the Company’s “Sustainable Development Best Practice Principles” to ensure systematic adherence and implementation.
This Plan is formulated in accordance with the “Environmental and Energy Management Regulations.” It aims to implement the Company’s environmental and energy policies, promote environmental protection and energy-saving initiatives, and mitigate the environmental impact of operational and investment activities. By enhancing energy efficiency, the Plan seeks to achieve low-carbon and sustainable development goals and serves as the primary basis for annual execution and information disclosure.
| Category | 2024 Baseline | 2030 Target |
| Scope 1 & 2 Emissions | 93.7 tCO₂e | Reduce by 25% (< 70.3 tCO₂e) |
| Scope 3 (Investments) | 121.5 tCO₂e | 33% of “Investment Book Value” to set reduction targets |
| Water Consumption | 2,566 m³ | Reduce by 10% (< 2,309 m³) |
| Category | Annual Goals | Execution Status |
| Energy Saving & Carbon Reduction |
|
|
| Green & Sustainable Investment |
|
|
| Training & Awareness |
|
|
醣基生醫股份有限公司
2017年9月27日登錄興櫃市場交易 (6586:TT)
公司所在地
台北,台灣
公司設立日期
2013
登錄公開市場
2017
公司官網
https://www.chopharma.com/cn/index.html